I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Lenvatinib in patients with unresectable hepatocellular car..:
Huynh, Jasmine
;
Cho, May Thet
;
Kim, Edward Jae-Hoon
...
qt66c48206. , 2022
Link:
https://escholarship.org/uc/item/66c48206
RT Journal T1
Lenvatinib in patients with unresectable hepatocellular carcinoma who progressed to Child-Pugh B liver function
UL https://suche.suub.uni-bremen.de/peid=base-ftcdlib:oai:escholarship.org:ark:_13030_qt66c48206&Exemplar=1&LAN=DE A1 Huynh, Jasmine A1 Cho, May Thet A1 Kim, Edward Jae-Hoon A1 Ren, Min A1 Ramji, Zahra A1 Vogel, Arndt PB eScholarship, University of California YR 2022 K1 Biomedical and Clinical Sciences K1 Clinical Sciences K1 Oncology and Carcinogenesis K1 Clinical Research K1 Cancer K1 Rare Diseases K1 Digestive Diseases K1 Liver Disease K1 Clinical Trials and Supportive Activities K1 6.1 Pharmaceuticals K1 Evaluation of treatments and therapeutic interventions K1 Child-Pugh B K1 hepatocellular carcinoma K1 lenvatinib K1 liver impairment K1 systemic treatment JF qt66c48206 LK http://dx.doi.org/https://escholarship.org/uc/item/66c48206 DO https://escholarship.org/uc/item/66c48206 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)